Implementation of Red Blood Cell Transfusion Recommendations in the Pediatric Intensive Care Unit
TRIP
Transfusion Recommendations Implemented in the PICU (TRIP)
2 other identifiers
interventional
200
1 country
2
Brief Summary
Evidence demonstrates that the risks of red blood cell transfusions outweigh benefits in many patients who are hospitalized in the pediatric intensive care unit with increased risk of organ dysfunction, infection, delirium, and death. Recommendations have been developed to restrict transfusion in patients who are unlikely to benefit; however, these recommendations have not been consistently adopted into clinical practice. This study examines use of targeted efforts (implementation strategies) to improve implementation of the recommendations, with a goal of reducing unnecessary transfusions and improving patient outcomes in critically ill children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2024
CompletedFirst Submitted
Initial submission to the registry
June 27, 2025
CompletedFirst Posted
Study publicly available on registry
August 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
August 7, 2025
July 1, 2025
2.1 years
June 27, 2025
July 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean change from baseline in transfusion recommendation adherence at 18 months (evidence-based threshold alert)
The investigators will assess the mean rate of nonadherent transfusions at monthly intervals in the pre- (12 months prior to CCDS tool initiation) and post-implementation period (18 months following CCDS tool initiation).
18 months
Secondary Outcomes (2)
Mean change from baseline in transfusion recommendation adherence at 18 months (transfusions that require clinical judgement)
18 months
Reach of computerized clinical decision support (CCDS) tools
18 months
Other Outcomes (17)
Unintended consequences of CCDS tools - Surveys - 6 months
Provider surveys at 6 months post-CCDS implementation
Unintended consequences of CCDS tools - Surveys - 12 months
Provider surveys at 12 months post-CCDS implementation
Unintended consequences of CCDS tools - Interviews 6 months
Provider surveys and interviews at 6 months post-CCDS implementation
- +14 more other outcomes
Interventions
Five implementation strategies will be employed in this study to enhance use of the blood transfusion recommendations. These include 1) building consensus, 2) provider education, 3) identifying and empowering champions ,4) use of computerized clinical decision support tools, and 5) provide quantitative metric-based feedback. Strategies 1-3 will occur prior to initiation of CCDS tools. All patients admitted to the PICU following the date of CCDS tool initiation will be considered to be part of the post-implementation phase. The investigators will collect data from the EHR on CCDS use and conduct provider surveys and interviews following CCDS tool initiation. Surveys and interviews will be both be conducted at 6 and 12 months post-CCDS tool initiation. Process and outcomes measures will be assessed before an after use of the implementation strategies.
Eligibility Criteria
You may qualify if:
- Employed at Lucile Packard Children's Hospital at Stanford University or the Children's Hospital of Philadelphia AND
- Employed in one of the following roles:
- PICU nurse
- PICU attending
- PICU fellow
- PICU resident
- PICU advanced practice provider
- Other physician or surgeon in subspecialties whose patients regularly receive transfusions in the PICU
- PICU TRIP implementation team member
- PICU nursing leader
- PICU physician leader
- Bood bank leader.
You may not qualify if:
- Unwilling to participate
- Directly report to the primary investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- Lucile Packard Children's Hospitalcollaborator
- Children's Hospital of Philadelphiacollaborator
- Agency for Healthcare Research and Quality (AHRQ)collaborator
Study Sites (2)
Lucile Packard Children's Hospital, Stanford University
Palo Alto, California, 94304, United States
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor, School of Medicine, Department of Pediatrics, Division of Pediatric Critical Care Medicine
Study Record Dates
First Submitted
June 27, 2025
First Posted
August 7, 2025
Study Start
November 30, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
August 7, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Because PEDSnet is not a public data repository, individual-level datasets are not typically released publicly outside of the network. Due to the complexity and privacy concerns associated with electronic health record data, certified PEDSnet data scientists lead the execution of all data analyses. While the data generated for this study cannot be shared publicly, our study team will make every effort to assist interested investigators and teams in leveraging the PEDSnet network to collaborate to obtain the entire dataset from this study or subset of data necessary for conducting secondary analyses or in answering a new, intended study question. Our study team will provide a final report(s) on our research findings and the investigators will relate that data can be made available for subsequent analyses through PEDSnet and provide necessary contact information to submit a Collaboration Request through PEDSnet or Dr. Steffen.